STOCK TITAN

FMR LLC (MXL) reveals 6.3% passive MaxLinear stake via Schedule 13G filing

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

FMR LLC filed a Schedule 13G reporting a passive ownership stake in MaxLinear Inc. common stock. FMR LLC and related entities beneficially own 5,474,232.11 shares, representing 6.3% of MaxLinear’s outstanding common stock as of 12/31/2025.

Abigail P. Johnson is listed as a reporting person with sole dispositive power over the same 5,474,232.11 shares. Within this total, Fidelity Small Cap Value Fund holds 4,586,449.00 shares, or 5.2% of MaxLinear’s common stock. The filing certifies the shares are held in the ordinary course of business and not for the purpose of changing or influencing control.

Positive

  • None.

Negative

  • None.

Insights

FMR reports a 6.3% passive stake in MaxLinear.

FMR LLC and affiliates disclose beneficial ownership of 5,474,232.11 MaxLinear common shares, or 6.3% of the class as of 12/31/2025. The filing uses Schedule 13G, which is typically for passive, non-control-seeking positions.

Within this total, Fidelity Small Cap Value Fund holds 4,586,449.00 shares, or 5.2% of outstanding stock. The filing states the securities were acquired and are held in the ordinary course of business and not with the purpose or effect of changing or influencing control.

The certification and use of Schedule 13G indicate a passive investment posture based on the information provided. Future ownership changes, if any, would normally appear in updated beneficial ownership reports or other company filings.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



FMR LLC
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:02/04/2026
Abigail P. Johnson
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
Date:02/04/2026

Comments accompanying signature: * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.

FAQ

What stake in MaxLinear Inc. (MXL) does FMR LLC report on this Schedule 13G?

FMR LLC reports beneficial ownership of 5,474,232.11 MaxLinear common shares, representing 6.3% of the outstanding class as of December 31, 2025. This reflects a significant institutional position disclosed under passive ownership rules.

How much MaxLinear (MXL) stock does Fidelity Small Cap Value Fund hold?

Fidelity Small Cap Value Fund’s interest in MaxLinear common stock is 4,586,449.00 shares, equal to 5.2% of the total outstanding common stock at 12/31/2025. This fund-level stake is part of the larger position reported by FMR LLC.

Is FMR LLC’s MaxLinear (MXL) position reported as passive or active?

The position is reported on a Schedule 13G, and the certification states the securities were acquired and are held in the ordinary course of business, not for changing or influencing control, indicating a passive investment posture under the disclosure rules.

What voting and dispositive power does FMR LLC report over MaxLinear (MXL) shares?

FMR LLC reports sole voting power over 5,466,713.00 shares and sole dispositive power over 5,474,232.11 shares, with no shared voting or dispositive power. These figures describe how the firm can vote and dispose of its MaxLinear holdings.

What role does Abigail P. Johnson have in the MaxLinear (MXL) ownership disclosure?

Abigail P. Johnson is a separate reporting person, showing sole dispositive power over 5,474,232.11 MaxLinear shares and no voting power. Her relationship is documented through a power of attorney authorizing signing on her behalf for this ownership report.

What does the Schedule 13G filing say about others benefiting from MaxLinear (MXL) shares?

The filing states one or more other persons have the right to receive or direct dividends and sale proceeds for the reported shares. It specifically notes Fidelity Small Cap Value Fund’s 4,586,449.00-share interest, exceeding 5% of MaxLinear’s outstanding common stock.